Global Drugs of Abuse Testing Country Shares and Market Segment Forecasts 2019-2023 - ResearchAndMarkets.com

This new 318-page report contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Monday, April 29, 2019
Information
Tags: 
Health, Pharmaceutical, Business, Marketing, Natural sciences, Physical sciences, Assay, Biochemistry, Titration, Market segmentation, Forecasting, Drug test
⚠generated by AI ↴
Summary
Key Points: 
  • This new 318-page report contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
  • The report provides test volume and sales forecasts by country and market segment for the following assays:
    During the next decade, the abused drug testing market will undergo significant transformation.
  • Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.
  • The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay.


The "Global
Drugs of Abuse Testing Country Shares and Market Segment Forecasts
2019-2023: US, Europe (France, Germany, Italy, Spain, UK), Japan"
report has been added to ResearchAndMarkets.com's
offering.

This new 318-page report contains 68 tables and provides analysis of the
global drug of abuse testing market, including emerging tests,
technologies, instrumentation, sales forecasts by country, market
shares, and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and
market segment for the following assays:

Amphetamines, Antidepressants, Barbiturates, Benzodiazepines,
Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates,
Phencyclidine (PCP), Propoxphene.

During the next decade, the abused drug testing market will undergo
significant transformation. These changes will be caused by convergence
of new and more stringent regulations; advances in diagnostic
technologies, system engineering, automation, and IT; and intensifying
competition. Some segments will start resembling commodity markets,
where product positioning and cost per test are more critical than
underlying technology. This evolving marketplace will create exciting
opportunities for a variety of new instruments, reagent systems, and
auxiliary products, such as specimen preparation devices, controls,
calibrators and others.

This report is a unique study designed to help current suppliers and
potential market entrants identify and evaluate emerging opportunities
and developed effective strategic responses. The study explores future
trends in the U.S., five major European countries and Japan; and
provides test volume and sales forecasts by country, market segment and
individual assay.

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • bioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken Chemical
  • Fujirebio
  • Grifols
  • Instrumentation Laboratory/Werfen
  • Kyowa Medex
  • Ortho-Clinical Diagnostics
  • PerkinElmer

For more information about this report visit https://www.researchandmarkets.com/r/fggggz

Copyright: 
Copyright Business Wire 2019